The ALS Association is proud to host this American Academy of Neurology presentation on ALS practice guidelines.

Slides:



Advertisements
Similar presentations
Amyotrophic Lateral Sclerosis (ALS)
Advertisements

MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
Amyotrophic lateral sclerosis (Lou Gehrig’s Disease)
Consent for Research Study A study for patients newly diagnosed with advanced glioblastoma (brain cancer): Learning whether a PET scan with F-fluoromisonidazole.
Feeding and Swallowing Disorders in Children
Amyotrophic Lateral Sclerosis (ALS)
Why do we test? 1.We want to prevent an outbreak of Tuberculosis in our campus community 2.We want to find those that are affected and get them treated.
Introduction to Palliative Care Dr. Sandhya Bhalla-Regev, MD
Amyotrophic Lateral Sclerosis (ALS) Sarah Belair and Hannah McLaughlin.
Allyson Bortoletto 3/6/14 Tara Holloway Psychology.
MANAGING FATIGUE during treatment Since fatigue is the most common symptom in people receiving chemotherapy, patients should learn ways to manage the fatigue.
Palliative Medicine, Pain Management, and Hospice Devon Neale, MD Assistant Professor Dept of Internal Medicine UNM School of Medicine.
In advanced cases coughing of blood Lung TB is the most common
Breast Cancer By George Rezk.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
Lou Gehrig's Disease By: Brittany Harden.
Palliative Care “101“. Definition Palliative Care Specialized medical care for people with serious illnesses. It is focused on providing patients with.
Exercise Management Cancer. Pathophysiology Cancer is not a single disease; it is a collection of hundreds of diseases that share the common feature of.
Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.
PATRICK CASEY FALL 2007 PARAMEDIC CLASS Amyotrophic Lateral Sclerosis.
Huntington Disease Genetic Disorder Project Alaukika Desai AP Biology Period 3.
Health Presentation Amyotrophic Lateral Sclerosis Zhenette Stevens.
LOU GEHRIG’S DISEASE.  Also known as Amyotrophic Lateral Sclerosis  Is a disease of the nerve cells in the brain and spinal cord that control voluntary.
REFERENCES 1. Karitzky J, Ludolph AC. Imaging and neurochemical markers for diagnosis and disease progression in ALS. Journal of the Neurological Sciences.
By Tash & Callum. What are the Functions of the Muscular System? Slide 3 What are the Major Organs That Make up the Muscular System? Slide 4-5 How do.
Amyotrophic Lateral Sclerosis (ALS)
HEALTH CARE DECISIONS ACROSS THE TRAJECTORY OF ILLNESS Susan Barbour RN MS ACHPN.
 Could you tell?  Tay-Sachs is a mental disorder, the fatty substance called ganglioside G M2 build up in tissues and nerve cells in the brain. 
Consent for Research Study A study for patients newly diagnosed with advanced glioblastoma (brain cancer): Learning whether a PET scan with F-fluoromisonidazole.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
Patient #5 ALS. Patient Background and Problems Patient #5- Andrew, a 45 year-old single father of two, comes to you in confidence. He’s noticed that.
Maximizing independence and quality at end of life. (Caroline Mathias O.T)
ALS: Amyotrophic Lateral Sclerosis Lou Gehrig’s Disease.
INTRODUCTION Your name, hometown Type of brain tumour, and treatment- where are you in your journey? What’s been most difficult? What do you hope for this.
CASE 1 Olivia Clements, Cade Mersch, and Julia Calhoun.
Neurological Disorders
PATIENT #5: ANDREW Ashton Crowe Rayvin Ewers Miranda McCormick.
Amyotrophic Lateral Sclerosis (ALS)
ALS Samuel Awad & Osama Jamali. Introduction ALS is one of the most common neuromuscular diseases worldwide, and people of all races and ethnic backgrounds.
Huntington's Disease By: Walter Gerring and Seth Little.
MULTIPLE SCLEROSIS BY EMILY HOWARD. Multiple Sclerosis (MS) Multiple sclerosis (or MS) is a chronic, often disabling disease of the immune system that.
PFF Teal = MAIN COLORS PFF Green = Light Green = Red = HIGHLIGHT COLORS Light Grey = Dark Grey =
Stephen Hawking. Biography Stephen William Hawking was born on 8 January In Oxford, England. Stephen then went on to Cambridge to do research in.
European Patients’ Academy on Therapeutic Innovation Ethical and practical challenges of organising clinical trials in small populations.
Motor neuron disease.
Amyotrophic Lateral Sclerosis (ALS). Also know as Lou Gehrig's Disease Named after the New York Yankees baseball star who played first base and was diagnosed.
Hospital mealtime volunteers workshop
Mondays with Andrew Tara and Annie. Andrew’s Story Andrew, a 45 year-old single father of two, comes to you in confidence. He’s noticed that the muscles.
Disabilities – Part One RECR 120. Parkinson’s Disease Non-motor symptoms such as loss of smell, constipation, and sleep disorders may appear years before.
Chapter 4.2 Eating Disorders
Patient #4 - Parkinson’s Disease
Amyotrophic Lateral Sclerosis (ALS)
Palliative Care Education Module
What is the NICE guideline on MND and what does it mean for you?
Communication Breakdown
Dr. Gary Mumaugh Bethel university
Understanding Your Role
Activity Communication Breakdown
Ashton Crowe Rayvin Ewers Miranda McCormick
Amyotrophic Lateral Sclerosis
Long Term Effects of Concussions
Tips For Finding An Alcohol Addiction Treatment Center
Ashton Crowe Rayvin Ewers Miranda McCormick
Diagnosis of Patient Six
Alzheimer's.
Clinical Implications
COPD Chronic Obstructive Lung Disease
COPD Chronic Obstructive Lung Disease
Bent Male Organ Problems: Get the 411 on Peyronie’s Disease and How to Treat It
Presentation transcript:

The ALS Association is proud to host this American Academy of Neurology presentation on ALS practice guidelines.

Update: The Care of the Patient with Amyotrophic Lateral Sclerosis Report of the Quality Standards Subcommittee of the American Academy of Neurology R. G. Miller, MD, FAAN; C. E. Jackson, MD, FAAN; E. J. Kasarskis, MD, PhD, FAAN; J. D. England, MD, FAAN; D. Forshew, RN; W. Johnston, MD; S. Kalra, MD; J. S. Katz, MD; H. Mitsumoto, MD, FAAN; J. Rosenfeld, MD, PhD, FAAN; C. Shoesmith, MD, BSc; M. J. Strong, MD; S. C. Woolley, PhD

Presentation Objectives To describe the process of making an evidence-based guideline To present the findings on and recommendations for care of people with amyotrophic lateral sclerosis (ALS) Drug, symptom, nutritional, and breathing therapies Multidisciplinary care in specialized ALS clinics Behavioral and thinking problems

Practice Guidelines Evidence-based statements to help doctors and patients make smart decisions about health care QSS TTA Subcommittees of the Practice Committee

AAN Guidelines Are Evidence-based ? Evidence-based Consensus-based

AAN Guideline Process Clinical Question Evidence Conclusions Recommendations

Clinical Questions The first step in developing guidelines is to ask important clinical questions. Questions look at areas of medicine where practice varies because of doctors’ understanding, beliefs, or attitudes. Questions must be answerable with published data. Answering the question must have the potential to improve care/outcomes.

Class I Class II Class III Class IV Rating the Evidence Randomized Masked Study Single Case Report Strong Weak Class I Class II Class III Class IV Level A  B  C  U

AAN Level of Recommendations Strong evidence = more than one high-quality scientific study Good evidence = at least one high-quality scientific study or two or more studies of a lesser quality Weak evidence = the studies, while supportive, are weak in design or strength of the findings Not enough evidence = either different studies have come to conflicting results or there are no studies of reasonable quality

Introduction What is ALS? ALS is a disease of weakening muscles. It is also called Lou Gehrig’s disease. The cause is unknown. In ALS, certain nerve cells in the brain and spinal cord become damaged. The affected cells are called motor neurons. These nerve cells send signals to the muscles in your arms and legs, and to the muscles for speaking, swallowing, and breathing.

Introduction Is there a cure for ALS? Will I die from it? ALS is serious. However, several therapies are now available to make life longer and easier. ALS progresses quickly and eventually leads to death. Most people with ALS die within three to five years from the onset of their first symptoms. However, 20% of people live longer.

Drug Therapies for Lengthening Life Are there any medications I can take to help me live longer? As of January 2010, riluzole is the only medication approved by the US Food and Drug Administration (FDA) to treat ALS. To a modest degree, riluzole slows the rate at which the disease worsens. Strong evidence shows that riluzole can prolong survival by two to three months. Experts suggest a greater benefit when riluzole is started early in the course of the disease. Riluzole is very safe but quite expensive. People who are newly diagnosed with ALS should discuss riluzole with their neurologists.

Multidisciplinary Care My doctor says my ALS will greatly affect my health and how I live my life. How should I go about getting the care I need? There is good evidence that visiting a multidisciplinary clinic can help people with ALS live longer and get the best possible care for their condition. Weak evidence shows that people with ALS who visit a multidisciplinary clinic have better quality of life.

Multidisciplinary Care My doctor says my ALS will greatly affect my health and how I live my life. How should I go about getting the care I need?, cont. These clinics are called multidisciplinary clinics because they provide a central location with many services that can help meet the needs of people with ALS. These services include sessions with a neurologist or rehabilitation specialist experienced in treating ALS, as well as a nurse case manager. These people will work to coordinate your care.

Multidisciplinary Care My doctor says my ALS will greatly affect my health and how I live my life. How should I go about getting the care I need?, cont. You also will meet with several other types of specialists, each of whom will focus on a particular area of care if you eventually need it. A physical therapist will work with you on toning muscles and maintaining range of motion and mobility. He or she also will assist you with choosing devices that help with movement.

Multidisciplinary Care My doctor says my ALS will greatly affect my health and how I live my life. How should I go about getting the care I need?, cont. An occupational therapist will help you and your caregiver with performing daily activities and adapting your home environment to meet your changing needs. A speech pathologist will help you develop different ways of communicating and give advice to make swallowing easier.

Multidisciplinary Care My doctor says my ALS will greatly affect my health and how I live my life. How should I go about getting the care I need?, cont. A dietitian will guide you with nutrition and maintaining your weight. For help with managing your breathing, you will work with a respiratory therapist. A social worker will work with you on how to cope with the disease and will identify additional resources to help you make the needed changes to your daily routine.

Nutritional Therapies Will having trouble swallowing affect my health? When you have problems swallowing, eating becomes very difficult. It is common to begin to choke and accidentally breathe in food you are trying to eat. Eventually weight loss and dehydration (not enough fluid in your system) can occur.

Nutritional Therapies How can this problem be treated? It is important to manage your swallowing problem so that you maintain good nutrition. Changing the texture of your food, taking smaller bites, and tucking your chin slightly while you swallow can help. You can also use a feeding tube called a percutaneous endoscopic gastrostomy (PEG) tube. These types of tubes are inserted through the skin into the stomach. or radiologically inserted gastrostomy (RIG) tube. There is good evidence that a PEG or RIG tube will likely help stabilize body weight and prolong survival.

Nutritional Therapies Do vitamin and nutritional supplements help people with ALS live longer? There is not enough evidence to show if vitamin or nutritional supplements help lengthen the lives of people with ALS. Specifically, studies of creatine, CoQ10, and Vitamin E (taken in high doses) do not show a benefit.

Drug Therapies for Symptoms Are there any medications I can take to treat my symptoms? There are medications available that can be very helpful in treating some symptoms of ALS. One symptom, uncontrolled laughing or crying, can be embarrassing and hard to manage. A person with ALS at times may cry excessively or laugh longer than expected at something that is only mildly funny.

Drug Therapies for Symptoms Are there any medications I can take to treat my symptoms?, cont. There is good evidence that a combination of the medications dextromethorphan (DM) and quinidine (Q) will lessen episodes of uncontrolled laughing or crying—both how severe they are and how often they happen. The side effects associated with DM and Q are dizziness, nausea, and sleepiness, so some people stop taking them. This combination of medications is currently awaiting FDA approval.

Drug Therapies for Symptoms Are there any medications I can take to treat my symptoms?, cont. Another symptom, drooling, happens because of swallowing problems. Drooling can be embarrassing, and trouble with swallowing the drool can be a health risk. The excess saliva can be accidentally breathed in, which in some cases contributes to pneumonia. There are several medications used to dry up the drool, but none of them has been studied for use in ALS.

Drug Therapies for Symptoms Are there any medications I can take to treat my symptoms?, cont. There is good evidence that injections of the medication botulinum toxin type B (BTxB) can help with drooling. The medication is injected into the glands near the jaw that make saliva. No serious side effects have been reported from use of BTxB.

Non-Drug Therapies for Symptoms Are there other ways of treating these symptoms? You can get radiation therapy for drooling if BTxB does not give relief. There is weak evidence that small amounts of radiation therapy might help. The side effects of this therapy are sore throat, nausea, and reddening of the skin. Ask your doctor whether radiation therapy would be a good choice for you.

Non-Drug Therapies for Symptoms Are there other ways of treating these symptoms?, cont. Also, services such as physical therapy, occupational therapy, and speech and language therapy can help you live better and more fully with your symptoms.

Non-Drug Therapies for Symptoms There doesn’t seem to be much evidence for therapies for symptoms. Why? In this guideline update, the authors were able to review only those studies that were specific to ALS. At this time, there are no studies available on use of these therapies in people with ALS.

Behavioral and Thinking Problems Is ALS a purely physical disease? ALS is mainly thought of as a physical disease. Many people with ALS have problems only with weakness of voluntary muscles. However, some people with ALS also develop problems with thinking or behavior changes, or both. For a small number of people with ALS, the effects on the brain can lead to a form of dementia.

Behavioral and Thinking Problems Is ALS a purely physical disease?, cont. The dementia that can occur with ALS progresses slowly and leads to changes in social behavior, loss of the ability to express feelings clearly and appropriately, and loss of the ability to reflect on things deeply. Other problems in this type of dementia are language problems and poor self-care.

Behavioral and Thinking Problems Is ALS a purely physical disease?, cont. Because these problems with thinking ability and behavior changes usually appear slowly, you may not notice them until they have become serious. It is important to try to detect and manage these problems as early as possible. Some people with ALS who develop these types of problems might not be willing to use important therapies that may prolong their survival or improve their quality of life.

Behavioral and Thinking Problems Is ALS a purely physical disease?, cont. There are tests available that screen for behavioral or thinking problems in people with ALS. Good evidence shows that people with ALS should be screened for possible problems with thinking ability or behavioral change.

Behavioral and Thinking Problems Is ALS a purely physical disease?, cont. If you are screened for a problem with thinking ability and the results show some problems, your doctor may suggest further testing. Talk to your doctor about whether such tests would be useful for you. Also ask your doctor about therapies that may help you and your caregivers to manage these changes.

Breathing Therapies How can problems with breathing be treated? Breathing problems develop in people with ALS because of weakening of the muscles that help with breathing. Treating breathing problems is very important. The most common cause of death from ALS occurs from weakening of breathing muscles.

Breathing Therapies How can problems with breathing be treated?, cont. It can be hard to know if you have a breathing problem because you may not notice it until it becomes serious. Talk to your doctor about available tests to detect a breathing problem.

Breathing Therapies How can problems with breathing be treated?, cont. If your doctor discovers that you have a breathing problem, he or she may recommend that you use an assisted-breathing device, also known as a noninvasive ventilation (NIV) device. Good evidence shows that using an NIV device will likely lengthen survival and slow the development of breathing problems. There is weak evidence that shows use of an NIV device will also improve quality of life.

How can problems with breathing be treated?, cont. Breathing Therapies How can problems with breathing be treated?, cont. Muscle weakness that affects breathing can also affect the ability to cough. If your cough is weak, you might have trouble clearing mucus and other fluids from your throat, which may lead to a chest infection. Assisted-coughing devices, also known as mechanical insufflation/exsufflation (MIE) devices, are available to help with coughing. Weak evidence shows that using an MIE device may help clear fluids from the throat, especially during a chest infection.

Conclusions There has been some progress in evaluating new therapies for people with ALS. More high-quality studies are available on multidisciplinary clinics, riluzole, breathing and nutrition, and therapies for some symptoms (laughing and crying behaviors, drooling). Unfortunately, many of these important treatments are not being used to their full potential. What’s more, there is still a great need for more and better research in many areas.

Future Research Lithium carbonate Nutrition Larger studies are in progress on whether lithium slows the rate at which the disease worsens and whether lithium lengthens survival. Nutrition Studies are needed on the best timing for inserting a feeding tube and for beginning antioxidant and supplement use.

Future Research Respiratory Management Evaluation is needed on when to start use of an NIV (breathing) device: impact on quality of life and survival. Comparison of the best techniques is needed for clearing phlegm and saliva.

Future Research Breaking the News Multidisciplinary Clinic Measures are needed on how and when to disclose an ALS diagnosis. Evaluation is needed on neurologists’ and patients’ attitudes toward strategies for breaking the news. Studies are needed on the effects of different strategies on patient satisfaction, preserving hope, and outcomes. Multidisciplinary Clinic Evaluation is needed on factors essential to benefits, best visit frequency, and economic concerns.

Future Research Symptom Management Behavioral and Thinking Problems Studies are needed on medication treatment for spasticity, cramps, constipation, drooling, laughing and crying behaviors, pain, depression, anxiety, fatigue, and exercise. Behavioral and Thinking Problems Evaluation is needed on diagnosis and research criteria, screening tests, and the history of and treatments for these problems.

Future Research Communication Palliative Care Evaluation is needed on communication strategies for people with weakness of their muscles for speech. Studies are needed that compare different communication strategies. Palliative Care Studies are needed on end-of-life symptom management, advanced directives, hospice, and spiritual care.

Acknowledgments The authors thank Gary Gronseth, MD; Thomas Getchius; Valerie Cwik, MD; Larry Brower; and Sid Valo for contributions to the practice parameters; Christina Metzler and Barbara Phillips, MS, OTR/L, for their contributions to the patient summary versions of the guidelines; and Sharon J. Matland, RN, MBA, for her contributions to both the practice parameters and the patient summary versions.

References For a complete list of references, please access the full guidelines at www.aan.com/guidelines

Questions/Comments

Thank you for your participation!

The ALS Association thanks the American Academy of Neurology and all of today’s presenters and participants.